Showing results (311-320 of 498) with videos related to
Sort By:
Pageof 50
Inorganic Chemistry|December 6, 2005
Synthesis of ortho- and meta-Re(I)-metallocarboranes in waterOyebola O Sogbein, Andrew E C Green, Paul Schaffer, et al.Oncotarget|December 3, 2016
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancerPietro Fici, Giulia Gallerani, Anne-Pierre Morel, et al.Arthritis Research & Therapy|February 11, 2017
Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritisSarah Salomon, Caroline Guignant, Pierre Morel, et al.Journal of Clinical Pharmacology|October 28, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain AmyloidosisMan Melody Luo, Peijuan Penny Zhu, Ivo Nnane, et al.Journal of Molecular Biology|December 25, 2019
Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light ChainsMartina Maritan, Margherita Romeo, Luca Oberti, et al.JAMA Cardiology|March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO StudyMasatoshi Minamisawa, Brian Claggett, David Adams, et al.Circulation. Heart Failure|September 5, 2019
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisMathew S Maurer, Sabahat Bokhari, Thibaud Damy, et al.Blood|May 28, 2017
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosisVaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2009
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysisGiovanni Montagna, Sara Raimondi, Guido Moro, et al.The New England Journal of Medicine|June 8, 2007
Eprodisate for the treatment of renal disease in AA amyloidosisLaura M Dember, Philip N Hawkins, Bouke P C Hazenberg, et al.Pageof 50